Loading institutional data...
Loading institutional data...
Held by 677 of 2,417 reporting institutions (99th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 15 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JPM | $912.4B | 17.2× | — | 5.0× | 2.8% | — | 31.3% | 15.7% | 13.4% | — | 1,974 |
| BAC | $354.0B | 13.4× | — | 3.1× | 6.8% | — | 27.0% | 10.1% | 4.9% | — | 1,281 |
| C | $208.2B | 18.0× | — | 2.4× | 5.6% | — | 16.8% | 6.7% | 2.5% | — | — |
| COF | $128.1B | 51.8× | — | 2.4× | 36.6% | — | 4.6% | 2.2% | 2.1% | — | 645 |
| USB | $94.5B | 13.1× | — | 3.3× | 4.4% | — | 26.4% | 11.6% | 9.2% | — | 685 |
| PNC | $92.1B | 14.0× | — | 4.0× | 7.2% | — | 30.3% | 11.5% | 5.9% | — | 677 |
| KEY | $22.7B | 14.1× | — | 3.0× | 62.7% | — | 24.3% | 9.0% | 6.0% | — | 248 |
| FHN | $11.2B | 12.7× | — | 3.3× | 7.2% | — | 28.7% | 11.1% | 8.1% | — | — |
| CFR | $9.8B | 15.9× | — | 4.4× | 8.3% | — | 29.0% | 14.2% | 14.2% | — | 149 |
| WBHC | $6.8B | 87.9× | — | 19.1× | 14.2% | — | 21.2% | 13.0% | 12.8% | — | — |
| CBU | $3.3B | 16.0× | — | 4.1× | 9.6% | — | 25.7% | 10.5% | 10.5% | — | 58 |
| PRK | $3.3B | 16.3× | — | 4.9× | 2.9% | — | 27.1% | 13.3% | 12.6% | — | 61 |
| BANC | $2.9B | 15.9× | — | 1.6× | -3.8% | — | 12.6% | 6.5% | 4.1% | — | 48 |
| NBTB | $2.8B | 15.9× | — | 15.0× | 10.4% | — | 92.5% | 8.9% | 8.3% | — | 62 |
| CASH | $1.6B | 9.7× | — | 1.9× | 5.3% | — | 22.1% | 21.7% | 20.6% | — | 46 |
| HAFC | $977M | 13.2× | 12.3× | 3.6× | 15.3% | — | 28.2% | 9.6% | 9.6% | 0.0× | 38 |
Peers = companies sharing PNC's sector (National Commercial Banks) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 60% of free cash flow, leaving room to grow it and fund buybacks. Last year: $2.63B dividends + $1.34B buybacks = $3.97B returned on $4.38B FCF.
9 consecutive years of dividend increases · 13%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 6%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
A reverse discounted cash flow is not shown for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Classified from the filings: SIC code.
Leverage ratios is not shown for a bank.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Classified from the filings: SIC code.
How much the company owes, how it's trended, and how comfortably it's serviced.
$11.71B of principal comes due within a year. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~14.3% on $72.74B of debt. Interest last disclosed in FY2023 (no longer broken out).
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.10B 100.0% | $21.55B 100.0% | $21.49B 100.0% | $21.12B 100.0% | $19.21B 100.0% | $16.90B 100.0% | $16.84B 100.0% | $16.19B 100.0% | $16.33B 100.0% | $15.16B 100.0% |
| Interest Expense | — | — | $10.39B 48.4% | $2.42B 11.5% | $487.0M 2.5% | $1.36B 8.1% | $3.80B 22.5% | $2.86B 17.7% | $1.71B 10.4% | $1.26B 8.3% |
| Pretax Income | $8.49B 36.7% | $7.24B 33.6% | $6.74B 31.3% | $7.47B 35.4% | $6.99B 36.4% | $3.43B 20.3% | $5.49B 32.6% | $5.49B 33.9% | $4.41B 27.0% | $5.25B 34.6% |
| Income Tax Expense | $1.49B 6.4% | $1.29B 6.0% | $1.09B 5.1% | $1.36B 6.4% | $1.26B 6.6% | $426.0M 2.5% | $901.0M 5.4% | $928.0M 5.7% | -$185.0M -1.1% | $1.27B 8.4% |
| Net Income | $7.00B 30.3% | $5.95B 27.6% | $5.65B 26.3% | $6.11B 28.9% | $5.72B 29.8% | $7.56B 44.7% | $5.42B 32.2% | $5.35B 33.0% | $5.39B 33.0% | $3.98B 26.3% |
| Per Share | ||||||||||
| EPS (Basic) | $16.60 | $13.76 | $12.80 | $13.86 | $12.71 | $16.99 | $11.43 | $10.79 | $10.49 | $7.42 |
| EPS (Diluted) | $16.59 | $13.74 | $12.79 | $13.85 | $12.70 | $16.96 | $11.39 | $10.71 | $10.36 | $7.30 |
| Weighted Avg Shares (Basic) | 396.0M | 399.0M | 401.0M | 412.0M | 426.0M | 427.0M | 447.0M | 467.0M | 481.0M | 494.0M |
| Weighted Avg Shares (Diluted) | 396.0M | 400.0M | 401.0M | 412.0M | 426.0M | 427.0M | 448.0M | 470.0M | 486.0M | 500.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 100th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 12% against ROIC 6% — 6% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Income Tax | 5.7 | 5.4 | 2.5 | 6.6 | 6.4 | 5.1 | 6.0 | 6.4 |
| Net Income | 33.0 | 32.2 | 44.7 | 29.8 | 28.9 | 26.3 | 27.6 | 30.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on PNC: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | not reported | not reported | 26.3% |
| FY2017 | not reported | not reported | 33.0% |
| FY2018 | not reported | not reported | 33.0% |
| FY2019 | not reported | not reported | 32.2% |
| FY2020 | not reported | not reported | 44.7% |
| FY2021 | not reported | not reported | 29.8% |
| FY2022 | not reported | not reported | 28.9% |
| FY2023 | not reported | not reported | 26.3% |
| FY2024 | not reported | not reported | 27.6% |
| FY2025 | not reported | not reported | 30.3% |
Leverage and buybacks account for 6 points of the 12% return on equity in FY2025. The business earns 6% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Converts 1.30x of reported profit into cash — adequate, without much margin.
Capex has been below depreciation for 7 consecutive years (0.00x on average over the last 5). Spending less than the asset base is consuming flatters free cash flow now and defers the cost — though depreciation also covers amortisation of acquired intangibles, which capex is not meant to replace.
Missing from our data, so excluded from this answer: share_based_compensation.
Leverage is not measurable this way for a bank.
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025. No cash figure on the matching balance sheet, so no coverage line is drawn.
Funded by deposits, so debt-weighted leverage and a WACC are not defined. Capital adequacy (CET1, LCR) is the right question and is not collected yet.
Missing from our data, so excluded from this answer: capital adequacy metrics for this archetype.
At $227.86, free cash flow must compound 7.57%/yr for 10 years. It has done -8.28%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | −36.7% | 7.6% |
| FY2021 | 54.8% | 7.6% |
| FY2022 | 25.9% | 7.6% |
| FY2023 | 11.3% | 7.6% |
| FY2024 | −22.1% | 7.6% |
| FY2025 | −44.4% | 7.6% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM (share count from the last fiscal year — the TTM window reports none).
The cost of capital could not be computed for this company, so the requirement is solved at the published 10% default — a different rate would move it materially.
| Step | Amount | Running total |
|---|---|---|
| Net income | $7.00B | $7.00B |
| Share-based comp | not reported | not reported |
| Other non-cash & working capital | −$2.61B | $4.38B |
| Operating cash flow | $4.38B | $4.38B |
| Capex | $0 | $4.38B |
| Free cash flow | $4.38B | $4.38B |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 0.4% | not reported | not reported |
| FY2021 | 13.7% | not reported | not reported |
| FY2022 | 9.9% | not reported | not reported |
| FY2023 | 1.8% | not reported | not reported |
| FY2024 | 0.3% | not reported | not reported |
| FY2025 | 7.2% | not reported | not reported |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -0.5 percent |
| FY2020 | 0.6 percent |
| FY2021 | -0.3 percent |
| FY2022 | -0.5 percent |
| FY2023 | -0.8 percent |
| FY2024 | -0.3 percent |
| FY2025 | 0.5 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 7 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Hesse Daniel Director | Grantindirect | 65 | $220.75 | — |
| 2026-10-01 | Khator Renu Director | Grantindirect | 119 | $220.75 | — |
| 2026-10-01 | Dachille Douglas A. Director | Grantindirect | 30 | $220.75 | — |
| 2026-10-01 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
Harshman Richard J Director |
| Grantindirect |
| 30 |
| $220.75 |
| — |
| 2026-10-01 | Niblock Robert A Director | Grantindirect | 59 | $220.75 | — |
| 2026-10-01 | Feldstein Andrew T Director | Grantindirect | 176 | $220.75 | — |
| 2026-10-01 | Cafaro Debra A Director | Grantindirect | 119 | $220.75 | — |
| 2026-10-01 | Salesky Bryan Scott Director | Grantindirect | 119 | $220.75 | — |
| 2026-08-13 | Juchno Stacy M. Executive Vice President | Open-market sale | 3,354 | $255.84 | $858k |
| 2026-07-22 | 2 co-filers Executive Vice President | Open-market sale | 1,200 | $252.19 | $303k |
| 2026-07-22 | 2 co-filers Executive Vice President | Gift | 72 | $0.00 | $0 |
| 2026-07-01 | Khator Renu Director | Grantindirect | 204 | $251.62 | — |
| 2026-07-01 | Salesky Bryan Scott Director | Grantindirect | 184 | $251.62 | — |
| 2026-07-01 | Dachille Douglas A. Director | Grantindirect | 51 | $251.62 | — |
| 2026-07-01 | Harshman Richard J Director | Grantindirect | 91 | $251.62 | — |
| 2026-07-01 | Niblock Robert A Director | Grantindirect | 102 | $251.62 | — |
| 2026-07-01 | Cafaro Debra A Director | Grantindirect | 303 | $251.62 | — |
| 2026-07-01 | Hesse Daniel Director | Grantindirect | 156 | $251.62 | — |
| 2026-07-01 | Feldstein Andrew T Director | Grantindirect | 392 | $251.62 | — |
| 2026-06-12 | Thomas Michael Duane Executive Vice President | Open-market sale | 1,500 | $238.14 | $357k |
| 2026-06-08 | Overstrom Alexander E. C. Executive Vice President | Open-market sale | 1,500 | $227.97 | $342k |
| 2026-06-05 | Novosel Stephanie Executive Vice President | Open-market sale | 1,800 | $228.73 | $412k |
| 2026-05-26 | 3 co-filers Group filing | Open-market saleindirect | 23,000 | $220.57 | $5.1m |
| 2026-05-26 | 3 co-filers Group filing | Open-market saleindirect | 18,000 | $220.57 | $4.0m |
| 2026-05-26 | 3 co-filers Group filing | Open-market saleindirect | 4,000 | $220.57 | $882k |
| 2026-04-22 | Hesse Daniel Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Pfinsgraff Martin Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Harshman Richard J Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Salesky Bryan Scott Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Niblock Robert A Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Alvarado Joseph Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Medler Linda R Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Feldstein Andrew T Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Cheshire Marjorie Rodgers Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Cafaro Debra A Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Dachille Douglas A. Director | Grant | 844 | $0.00 | — |
| 2026-04-22 | Khator Renu Director | Grant | 844 | $0.00 | — |
| 2026-04-17 | 2 co-filers President | Grant | 4,551 | $0.00 | $0 |
| 2026-04-17 | 2 co-filers President | Tax withholding | 2,071 | $224.81 | $466k |
| 2026-04-01 | Salesky Bryan Scott Director | Grantindirect | 125 | $209.24 | — |